Design of retroviral vectors and helper cells for gene therapy.
about
Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effectsGene Therapy: The Potential Applicability of Gene Transfer Technology to the Human Germline.Retroviral Vector Biosafety: Lessons from SheepProgresses towards safe and efficient gene therapy vectorsCARs in chronic lymphocytic leukemia -- ready to driveMurine retroviruses re-engineered for lineage tracing and expression of toxic genes in the developing chick embryo.Gene therapy for cerebral vascular disease: update 2003.Transduction of human immunodeficiency virus type 1 vectors lacking encapsidation and dimerization signals.Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology.Host cell factors and functions involved in vesicular stomatitis virus entry.Dexamethasone and mifepristone increase retroviral infectivity through different mechanisms.Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?".Designing T cells for cancer immunotherapyEngineering CAR-T cells.An XMRV derived retroviral vector as a tool for gene transfer.Enhancement of enveloped virus entry by phosphatidylserine.CAR-T cell therapy in ovarian cancer: from the bench to the bedside.Ectopic Expression of Human DPPA2 Gene in ESCC Cell Line Using Retroviral System.Viral Vectors in Gene Therapy.The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
P2860
Q22242357-F9CC7317-C76F-4F10-AEFC-62204916BA36Q24791385-673223DA-7DC1-4B47-9FF4-EF0B32A19FEEQ24792892-250373EC-6DF0-4B8E-A5D6-EA30766579DAQ26781432-0BF870EB-48DC-49DF-8B1A-92E226C8D0CAQ26830526-6BA56416-9BD4-4BE0-8555-4FD1EDEB5183Q34078563-9B1076EE-33C4-49DE-95CE-9143C71ADC14Q35045240-73D5D581-F540-4F38-A3F3-1ACADAEC2E89Q36099054-3BE0A0A0-C82D-49A4-BAE2-0D1649FA9FCEQ36870444-FDC05604-45BC-4A8E-8865-871F175D7BA8Q37033185-19A9FA70-8A3B-4EBB-B81E-ECE25D4293DBQ37337525-484D096D-B1BA-41AB-BF12-B4343F3D8D76Q37585288-7204FB1A-B2A5-4BA3-A653-666CD288A4F3Q37737817-9E7BA96E-2B0B-4701-950F-75F058CC37C9Q39399864-71BDB8C5-5527-466B-AB28-CC847737BDEAQ39529062-78E473F1-D724-452A-B2AC-BF3506E93BCEQ40384538-849F37C9-001B-4300-82B4-C9DEB6F71121Q42362802-C6B0A5BF-DF23-4A80-8AB1-0CFED78C24C0Q55039045-0ADAE5AE-C901-434B-8121-6FC70B675B49Q55408780-FCE13937-9B17-474C-B115-8E537F0E6636Q58767159-D94552E0-B7B4-494B-9709-155F751AE533
P2860
Design of retroviral vectors and helper cells for gene therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Design of retroviral vectors and helper cells for gene therapy.
@ast
Design of retroviral vectors and helper cells for gene therapy.
@en
Design of retroviral vectors and helper cells for gene therapy.
@nl
type
label
Design of retroviral vectors and helper cells for gene therapy.
@ast
Design of retroviral vectors and helper cells for gene therapy.
@en
Design of retroviral vectors and helper cells for gene therapy.
@nl
prefLabel
Design of retroviral vectors and helper cells for gene therapy.
@ast
Design of retroviral vectors and helper cells for gene therapy.
@en
Design of retroviral vectors and helper cells for gene therapy.
@nl
P1476
Design of retroviral vectors and helper cells for gene therapy
@en
P2093
P304
P577
2000-12-01T00:00:00Z